CRA was retained by the respondent in an ICC arbitration in which the claimant alleged an inappropriate termination of a supply agreement relating to material used in a vaccine. CRA’s analysis demonstrated that changes in the commercial market circumstances for the final product had eroded the returns to untenable levels, showing that it would be in neither party’s interests to maintain the supply agreement.
Investment treaty disputes in the life sciences industry
In its global scale and economic impact, the life sciences industry presents unique considerations for investment treaty arbitrations. Recently, the COVID-19...